FDA Inspection 1051161 — David Adams
The FDA completed an inspection of David Adams on Mar 16, 2018 in Le Kremlin Bicetre Cedex. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Le Kremlin Bicetre Cedex (France)
Additional details
Clinical Investigator (CI)